Stephen Hahn steps down as CEO of Flagship biotech; A new era at AbbVie partner Gubranews2025-08-15T11:00:03+00:00August 15th, 2025|Endpoints News|
Pharma’s IRA fight persists as it looks to Supreme Court, lobbies for changesnews2025-08-14T18:55:18+00:00August 14th, 2025|Endpoints News|
Lilly plans to raise prices in Europe in response to Trump’s ‘most favored nation’ pushnews2025-08-14T18:44:46+00:00August 14th, 2025|Endpoints News|
While decrying mRNA for Covid, Kennedy says he supports mRNA in oncologynews2025-08-14T17:45:26+00:00August 14th, 2025|Endpoints News|
In the scramble for capital, biotechs turn to royalty dealsnews2025-08-14T15:11:39+00:00August 14th, 2025|Endpoints News|
Schrödinger ends work on blood cancer drug after two patient deathsnews2025-08-14T14:52:12+00:00August 14th, 2025|Endpoints News|
Aquestive’s $85M offering and royalty deal; Basilea gets rights to UTI drug candidatenews2025-08-14T14:32:53+00:00August 14th, 2025|Endpoints News|
Trump executive order focuses on stockpiling raw materials for ‘critical’ drugsnews2025-08-14T14:12:16+00:00August 14th, 2025|Endpoints News|
More layoffs at Evotec; Savara to work with Fujifilm as manufacturing partnernews2025-08-14T13:22:58+00:00August 14th, 2025|Endpoints News|
